US Stock MarketDetailed Quotes

HUGE FSD Pharma

Watchlist

0.1383
-0.0045-3.15%

Close Jul 19 16:00 ET

6.37MMarket Cap-553P/E (TTM)

FSD Pharma Stock Forum

Stock Region

Jun 28 16:50

Biopharmaceutical Company Confirms Arbitration Award of $3,059,998

FSD Pharma, Inc. secures a decisive legal victory, confirming an arbitration award of $3,059,998 plus interest against Dr. Raza Bokhari, who presently holds the position of Chairman and CEO at Medicus Pharma Ltd.
FSD Pharma, Inc., a biopharmaceutical company known for its dedication to the development of innovative treatments for neurodegenerative and metabolic disorders as well as alcohol misuse disorders, recently emerged victor...

Hazy0ne

Jun 28 13:55

$FSD Pharma(HUGE.US)$
GARBAGE

Volatility Rider

Jun 28 12:16

I think you all should see this new IPO stock. Just launched
$LandBridge(LB.US)$

Smileyphg

Jun 28 07:23

$FSD Pharma(HUGE.US)$ come on baby!

Trytosaveabit

Jun 28 06:38

News

$FSD Pharma(HUGE.US)$ FSD Pharma Inc. (NASDAQ:HUGE)(CSE:HUGE)(FRA:0K9A) ("FSD Pharma"), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions to address ailments affecting millions worldwide, today announces that on June 27, 2024, the United States District Court for the Eastern District of Pennsylvania confirmed FSD Pharma, Inc.'s motion for entry of judgment is granted and judgment is entered in favour of FSD Pharma and against Dr. Raza Bo...

DamZhamEnterprise

Jun 14 09:29

$FSD Pharma(HUGE.US)$ epic dilution to fund the"innovative" ventures

Trytosaveabit

Jun 13 06:44

Update

$FSD Pharma(HUGE.US)$ FSD Pharma Enters Exclusive Option Agreement With University Of Southern California To Evaluate Dietary Supplement Technology For Commercialization

Jaguar8

Jun 4 06:32

NEWS

$FSD Pharma(HUGE.US)$
FSD Pharma Receives Institutional Review Board Approval to Study the Safety and Efficacy of Unbuzzd(TM) in Acute Alcohol Intoxication
FSD Pharma has received Institutional Review Board (IRB) approval for its METAL-2 trial in the USA to study the safety and efficacy of Unbuzzd(TM) in acute alcohol intoxication. This approval allows the company to begin recruiting participants and planning the clinical study. Dr. Andrzej Chruscinski, Vice-President of Clinical and Scienti...